OM Pharma
OM Pharma, headquartered in Switzerland (CH), is a prominent player in the biopharmaceutical industry, specialising in innovative therapies for serious diseases. Founded in 1987, the company has established a strong presence in Europe and beyond, focusing on areas such as immunology and infectious diseases. With a portfolio that includes unique biological products and advanced therapies, OM Pharma is dedicated to addressing unmet medical needs. Their commitment to research and development has led to significant milestones, including the successful launch of several key products that enhance patient outcomes. Recognised for its expertise and innovation, OM Pharma continues to strengthen its market position, contributing to advancements in healthcare and improving the lives of patients worldwide.
DitchCarbon Score
How does OM Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OM Pharma's score of 6 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OM Pharma's reported carbon emissions
OM Pharma, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a broader commitment to environmental responsibility. As OM Pharma navigates this landscape, it may adopt industry-standard practices and targets in the future to align with global climate objectives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OM Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
